The U.S. neuropathic pain treatment market is estimated to be valued at US$2,064.9 million in 2022 and is expected to exhibit a CAGR of 4.8% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:Neuropathic pain refers to chronic pain caused by injury or dysfunction of the nervous system. It affects millions of Americans and can...